PH 38 (CLINPHARM 2)
🇬🇧
In Inglés
In Inglés
Practique preguntas conocidas
Manténgase al día con sus preguntas pendientes
Completa 5 preguntas para habilitar la práctica
Exámenes
Examen: pon a prueba tus habilidades
Pon a prueba tus habilidades en el modo de examen
Aprenda nuevas preguntas
Modos dinámicos
InteligenteMezcla inteligente de todos los modos
PersonalizadoUtilice la configuración para ponderar los modos dinámicos
Modo manual [beta]
Seleccione sus propios tipos de preguntas y respuestas
Modos específicos
Aprende con fichas
Completa la oración
Escuchar y deletrearOrtografía: escribe lo que escuchas
elección múltipleModo de elección múltiple
Expresión oralResponde con voz
Expresión oral y comprensión auditivaPractica la pronunciación
EscrituraModo de solo escritura
PH 38 (CLINPHARM 2) - Marcador
PH 38 (CLINPHARM 2) - Detalles
Niveles:
Preguntas:
60 preguntas
🇬🇧 | 🇬🇧 |
Pharmacologic Therapy For severe acne | 1.Antiandrogens 2.Isotretinoin 3.Topical and oral antibiotics |
Pharmacologic Therapy For severe acne | 1.Antiandrogens 2.Isotretinoin 3.Topical and oral antibiotics |
Pharmacologic Therapy For severe acne | 1.Antiandrogens 2.Isotretinoin 3.Topical and oral antibiotics |
ACNE VULGARIS FOUR MAJOR ETIOLOGICAL FACTORS | 1 Increased sebum production 2 Hormonal influences 3 Bacterial colonization of the duct with Propionibacterium acnes 4 Production of inflammation in acne sites |
Increased glucocorticoid secretion => | Potentiation of the effects of androgens |
Foods that are perceived to exacerbate acne | 1 Chocolate 2 Cola drinks 3 Milk 4 Milk products |
THE PATHOGENESIS OF ACNE 4 stages | 1.Increased follicular keratinization 2.Increased sebum production 3.Bacterial lipolysis of sebum triglycerides to free fatty acids 4.Inflammation |
Acne results from this primary lesion of both noninflammatory and inflammatory acne | Obstructed sebaceous follicle aka microcomedone |
Acne Vulgaris Pathophysiology (step by step) | 1 Acne results from obstructed sebaceous follicle (microcomedone) 2 Cells adhere to each other; forms dense keratinous plug 3 Sebum becomes trapped behind keratin plug 4 sebum solidifies; forms OPEN or CLOSED comedone 5 Pooling of sebum increases Anaerobic Bacterium Propionibacterium acnes; generate T cell response; results to inflammation |
1 first clinically visible lesion of acne. It takes 5 months to develop. 2 plug extends to upper canal and dilates opening; either oxidized lipid and melanin (black color) or to the impacted mass of horny cells | 1 Closed comedone, or whitehead 2 OPEN comedone or black head |
Acne that is characterized by open and closed comedones is termed as? | Noninflammatory Acne |
1 Propionibacterium acnes also produces enzymes which increase the permeability of the follicular wall, leading to: 2 Nodules, and cysts and may lead to __ | 1 Rupture, releasing keratin, hair, lipids and irritating free fatty acids into the dermis 2 scarring |
TYPES OF ACNE | 1 Blackheads 2 Whiteheads 3 Papules 4 Pustules 5 Nodules 6 Cysts |
ACNE VULGARIS Nonpharmacologic Therapy | 1.Cleansing 2.Proper shaving 3.Comedone extraction 4.Ultraviolet light 5.Prevention of Cosmetic Acne |
Pharmacologic Therapy For mild to moderate acne | 1.Topical retinoids 2.Salicylic acid 3.Benzoyl peroxide 4.Sulfur 5.Resorcinol |
Pharmacologic Therapy For moderate to severe acne | 1.Benzoyl peroxide 2 Topical antibiotics (Clindamycin/Clindamycin + Benzoyl peroxide) 3 Oral antibiotics (erythromycin, tetracycline, or minocycline) 4 Retinoids (tretinoin, adapalene, and tazarotene, and azeleic acid). |
Pharmacologic Therapy For severe acne | 1.Antiandrogens 2.Isotretinoin 3.Topical and oral antibiotics |
Pharmacologic Therapy Anti-sebum agents | 1 Oral Contraceptives (norgestimate + ethinyl estradiol or norethindrone acetate + ethinyl estradiol) 2.Spironolactone 3.Cyproterone Acetate 4.Oral Corticosteroids 5.Oral Isotretinoin |
Pharmacologic Therapy Pharmacologic Cleansing Options: | 1.Medicated Soaps and Washes |
Psoriasis two peak ages of onset | 20 to 30 years of age. 50 to 60 years of age. |
Is CENTRAL to the clinical presentation of psoriasis | Keratinocyte proliferation |
PSORIASIS TWO MAJOR ETIOLOGICAL FACTORS: | 1 Genetics 2 Predisposing and precipitating factors |
PSORIASIS Predisposing FACTORS | 1 horse-fly bite (Koebner phenomenon) 2 viral or streptococcal infection 3 use of β-adrenergic blockers |
PSORIASIS Precipitating FACTORS | 1 NSAIDS 2 antimalarials 3 β -adrenergic blockers 4 withdrawal of corticosteroids |
Are responsible for the EPIDERMAL HYPERPLASIA and DERMAL INFLAMMATION that is seen in psoriasis. | Interaction of dermal dendritic cells activated T cells of TH-1, TH-17 lineage with cytokines and growth factors |
TYPES OF PSORIASIS | 1 Plaque 2 Flexural or Intertriginous 3 Seborrheic 4 Scalp 5 Acrodermatitis of Hallopeau 6 Palm or soles 7 Erythodermic 8 Guttate 9 Generalized Pustular Psoriasis |
Diagnostic Tests of PSORIASIS | 1.Body surface area (BSA) 2.Psoriasis Area and Severity Index (PASI) 3.Physician’s Global Assessment (static PGA) 4 Quality-of-life measures such as the Dermatology Life Quality Index (DLQI) or the Short Form (SF-36) Health Survey. |
Nonpharmacologic Therapy | 1.Stress-reduction strategies 2.Moisturizers 3.Oatmeal baths 4.Skin protection using sunscreens. |
PSORIASIS Pharmacologic Therapy | Topical Therapies 1 Corticosteroids (mainstay for the majority) 2 Vitamin D3 Analogues (calcipotriol (calcipotriene), calcitriol (the active metabolite of vitamin D), and tacalcitol) 3 Retinoids (Tazarotene) 4 Anthralin (direct antiproliferative effect) 5 Coal Tar (one of the earliest agents) 6 Salicylic Acid (for patients with scalp psoriasis) 7 Calcineurin Inhibitors (for atopic dermatitis) |
PSORIASIS Pharmacologic Therapy 1 Phototherapies and Photochemotherapy: | 1.UVB 2.NB-UVB (Narrowband UVB) 3.UVA 4.PUVA (UVA + Psoralens) |
PSORIASIS Pharmacologic Therapy 1 Systemic Therapies: | 1.Acitretin 2.Cyclosporine 3.Methotrexate |
Skin consists of | 1 Outer Epidermis 2 Inner Epidermis |
Epidermis parts | 1 stratum basale (basal layer), 2 stratum spinosum (prickle cell layer) 3 stratum granulosum (granular layer) 4 stratum corneum (horny layer) |
PATHOPHYSIOLOGY: 1 Localized DRUG-INDUCED REACTIONS 2 Allergic DRUG-INDUCED REACTIONS Depend on inducing an immune response from the host Classified as: | 1 Chemical vaginitis (vaginal douches, spermicides, and imidazoles) 2 Blistering Exanthematous Pustular eruptions Urticarial |
S/S: hives, extremely pruritic red raised wheals, angioedema, and mucous membrane swelling that typically occurs within minutes to hours | Urticaria and angioedema |
Complex urticarial eruptions S/S: fever, rash (usually urticarial), and arthralgias, usually within 1–3 weeks after starting the offending drug. | Serum sickness-like reactions |
Immune complex or cell-mediated allergic responses S/S: generalized tender/painful bullous formation with fever, headache, and respiratory symptoms, that rapidly deteriorate. | Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis (SJS/TEN) |
Simple pustular eruptions caused by medications that induce acne (whiteheads or blackheads). onset is usually about one to three weeks. | Acneiform drug reactions |
Complex pustular eruption S/S: acute onset (within days after starting the offending drug), fever, diffuse erythema, and many pustules. | Acute generalized exanthematous pustulosis (AGEP) |
May be related to increased melanin hydantoins direct deposition - silver, mercury, tetracyclines, antimalarials other mechanisms (some cytotoxic drugs) | Hyperpigmentation |
May be phototoxic or photoallergic. Drugs that induce phototoxic reactions absorb ultraviolet A (UVA) light | Photosensitivity |
COMMON SKIN DISORDER | 1 CONTACT DERMATITIS 2 DIAPER DERMATITIS 3 SKIN CANCER |
Skin inflammation caused by irritants or allergic sensitizers Eczematous inflammation, with erythema, vesicles, papules, crusting, fissuring, or scaling | CONTACT DERMATITIS |
1 contact dermatitis that occur several days later, immunologic response 2 contact dermatitis that occur few hours, organic substance | 1 Allergic CD 2 Irritant CD |
1 causes red plaques, papules, and pustules in diaper rash | 1 Candida species |
DRUG-INDUCED REACTIONS MANAGEMENT Management & Treatment 1 IF severe case: 2 IF w/ fever: 3 IF SJS/TEN: | Termination of suspected drug 1 IF severe case: -- Corticosteroids 2 IF w/ fever: -- Acetaminophen 3 Broad spectrum antibiotics & vancomycin, IVIG |
CONTACT DERMATITIS MANAGEMENT 1) 1st goal: 2) 2nd goal: | . 1 identify, withdraw, avoid offending agent using Patch Test -> gold standard 2 provide symptomatic relief while decreasing skin lesions. -> cold compresses -> topical corticosteroids |
DIAPER DERMATITIS MANAGEMENT 1 Non pharmacologic 2 Drugs 3 DOC for candidal rash: | 1) Frequent diaper changes Air drying Gentle cleansing 2) Zinc oxide (astringent) Petrolatum (moisture) 3 imidazole |
SKIN CANCER MANAGEMENT 1 Squamous Cell Carcinoma (SCC) treatment 2 Basal Cell Carcinoma (BCC) 3 Malignant melanoma - give also drug for metastatic melanoma | . 1 surgical excision 2 may involve surgical excision; topical agents (imiquimod or antineoplastic agents, such as 5-fluorouracil) 3 antineoplastic therapy, (temozolomide) or (dacarbazine for metastatic melanoma) |